Else Nutrition Holdings, Inc. (BABY) Stock Analysis | Price, Returns, Financials & Key Metrics

Price Point

High/Low

1Day

52 Week

Valuation

Technical

Day's Volume

CASH

39.99 k

Shareholding (Dec 2023)

FII

0.00%

Held by 1 FIIs

DII

100.0%

Held by 0 DIIs

Promoter

0.00%

Score

Click here to find our call on this stock

Strong Sell

Sell

Hold

Buy

Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.Unlock 29 Markets

Dashboard

CASH AND EQV(HY) Lowest at CAD 2.33 MM
DEBT-EQUITY RATIO (HY) Highest at 14.15 %
PRE-TAX PROFIT(Q) Lowest at CAD -4.09

Risky - No result in last 6 months

Consistent Underperformance against the benchmark over the last 3 years

Mojo Parameters

Stock DNA

Industry

Pharmaceuticals & Biotechnology

Market cap

CAD 5 Million (Micro Cap)

P/E

NA (Loss Making)

Industry P/E

Dividend Yield

0.00%

Debt Equity

-0.83

Return on Equity

1,095.30%

Price to Book

-5.27

Revenue and Profits:

Net Sales:

1 Million

(Quarterly Results - Dec 2024)

Net Profit:

-4 Million

Total Returns

Total Returns (Price + Dividend)

TimePeriod

Price Return

Dividend Return

Total Return

3 Months

-15.0%

6 Months

13.33%

1 Year

-15.0%

2 Years

-94.69%

3 Years

-96.67%

4 Years

0.0%

5 Years

0.0%

Else Nutrition Holdings, Inc. for the last several years.

Risk Adjusted Returns v/s

News & Corporate Actions

News

No Recent News for the Company

Announcements

No announcement available

Corporate Actions

No corporate action available

Key Factors

Quality key factors

Factor

Value

Sales Growth (5y)

46.85%

EBIT Growth (5y)

-163.39%

EBIT to Interest (avg)

-15.34

Debt to EBITDA (avg)

Negative Net Debt

Net Debt to Equity (avg)

0.27

Sales to Capital Employed (avg)

2.65

Tax Ratio

Dividend Payout Ratio

Pledged Shares

Institutional Holding

0.00%

ROCE (avg)

ROE (avg)

Valuation key factors

Factor

Value

P/E Ratio

NA (Loss Making)

Industry P/E

Price to Book Value

-3.96

EV to EBIT

-0.45

EV to EBITDA

-0.46

EV to Capital Employed

4.79

EV to Sales

0.70

PEG Ratio

Dividend Yield

ROCE (Latest)

-1068.20%

ROE (Latest)

Negative BV

Technicals key factors

Indicator

Weekly

Monthly

MACD

Mildly Bullish

RSI

Bearish

No Signal

Bollinger Bands

Mildly Bullish

Sideways

Moving Averages

Mildly Bearish (Daily)

KST

Mildly Bearish

Bearish

Dow Theory

Mildly Bullish

No Trend

OBV

Mildly Bullish

No Trend

Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned

Shareholding

Shareholding Snapshot : Dec 2023

Shareholding Compare (%holding)

Majority shareholders

Foreign Institutions

Domestic Funds

Held in 0 Schemes (0%)

Foreign Institutions

Held by 1 Foreign Institutions (0.0%)

Strategic Entities with highest holding

Highest Public shareholder

Financial

[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Dec'24 - YoY",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in quarter ended Dec 2024 is -41.67% vs 0.00% in Dec 2023",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in quarter ended Dec 2024 is 11.76% vs 5.56% in Dec 2023",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Dec'24",
        "Dec'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "1.40",
          "val2": "2.40",
          "chgp": "-41.67%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "-3.80",
          "val2": "-4.40",
          "chgp": "13.64%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "0.00",
          "val2": "0.10",
          "chgp": "-100.00%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "-0.60",
          "val2": "-1.10",
          "chgp": "45.45%",
          "chgp_class": "positive"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "-4.50",
          "val2": "-5.10",
          "chgp": "11.76%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "-2,736.30%",
          "val2": "-1,879.80%",
          "chgp": "-85.65%",
          "chgp_class": "negative"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Dec'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Dec 2024 is -14.89% vs 10.59% in Dec 2023",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Dec 2024 is 2.56% vs 11.36% in Dec 2023",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Dec'24",
        "Dec'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "8.00",
          "val2": "9.40",
          "chgp": "-14.89%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "-14.40",
          "val2": "-16.60",
          "chgp": "13.25%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "0.10",
          "val2": "0.10",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Exceptional Items",
          "val1": "-0.60",
          "val2": "2.10",
          "chgp": "-128.57%",
          "chgp_class": "negative"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "-15.20",
          "val2": "-15.60",
          "chgp": "2.56%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "-1,845.90%",
          "val2": "-1,817.20%",
          "chgp": "-2.87%",
          "chgp_class": "negative"
        }
      ]
    }
  }
]

Quarterly Results Snapshot (Consolidated) - Dec'24 - YoY

Dec'24

Dec'23

Change(%)

Net Sales

1.40

2.40

-41.67%

Operating Profit (PBDIT) excl Other Income

-3.80

-4.40

13.64%

Interest

0.00

0.10

-100.00%

Exceptional Items

-0.60

-1.10

45.45%

Consolidate Net Profit

-4.50

-5.10

11.76%

Operating Profit Margin (Excl OI)

-2,736.30%

-1,879.80%

-85.65%

USD in Million.

Compare with Peers

Net Sales

YoY Growth in quarter ended Dec 2024 is -41.67% vs 0.00% in Dec 2023

Consolidated Net Profit

YoY Growth in quarter ended Dec 2024 is 11.76% vs 5.56% in Dec 2023

All Quarterly Results

Annual Results Snapshot (Consolidated) - Dec'24

Dec'24

Dec'23

Change(%)

Net Sales

8.00

9.40

-14.89%

Operating Profit (PBDIT) excl Other Income

-14.40

-16.60

13.25%

Interest

0.10

Exceptional Items

-0.60

2.10

-128.57%

Consolidate Net Profit

-15.20

-15.60

2.56%

Operating Profit Margin (Excl OI)

-1,845.90%

-1,817.20%

-2.87%

USD in Million.

Compare with Peers

Net Sales

YoY Growth in year ended Dec 2024 is -14.89% vs 10.59% in Dec 2023

Consolidated Net Profit

YoY Growth in year ended Dec 2024 is 2.56% vs 11.36% in Dec 2023

All Annual Results

Company CV

About Else Nutrition Holdings, Inc.

Else Nutrition Holdings, Inc.

Pharmaceuticals & Biotechnology

Else Nutrition Holdings Inc., formerly ASB Capital Inc., is a Canada-based company. The Company is the developer of food products and formula nutrition for infants and toddlers.

Company Coordinates

Company Details

Fairmont Pacific Rim , VANCOUVER BC : V6C 0B2

Tel: 1 604 6309795

https://elsenutrition.com/

Registrar Details